June 29, 2020 / 7:59 PM / 7 days ago

BRIEF-FDA Approves First-Line Immunotherapy For Patients With Msi-H/Dmmr Metastatic Colorectal Cancer

June 29 (Reuters) - FDA:

* FDA APPROVES FIRST-LINE IMMUNOTHERAPY FOR PATIENTS WITH MSI-H/DMMR METASTATIC COLORECTAL CANCER

* FDA - GRANTED APPROVAL OF KEYTRUDA TO MERCK & CO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below